Inactive Instrument

Walgreens Boots Alliance Inc Stock price Nyse

Equities

US9314221097

Drug Retailers

End-of-day quote Nyse
- USD 0.00% Intraday chart for Walgreens Boots Alliance Inc
Sales 2024 * 144B Sales 2025 * 150B Capitalization 17.84B
Net income 2024 * 2.12B Net income 2025 * 2.83B EV / Sales 2024 * 0.18 x
Net Debt 2024 * 7.5B Net Debt 2025 * 7.15B EV / Sales 2025 * 0.17 x
P/E ratio 2024 *
12.7 x
P/E ratio 2025 *
8.29 x
Employees -
Yield 2024 *
6.13%
Yield 2025 *
5.58%
Free-Float 60.77%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 64 23-10-22
Chairman 83 12-07-31
Director of Finance/CFO 45 16-01-31
Members of the board TitleAgeSince
Director/Board Member 57 22-10-26
Director/Board Member 67 20-10-28
Director/Board Member 68 10-03-31
More insiders
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (90.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2022, the activity is ensured through 13,343 outlets (including 8,889 in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.4%). The remaining sales (1.4%) are from the healthcare Net sales break down geographically as follows: the United States (83.5%), Germany (8.4%), the United Kingdom (6.7%) and other (1.4%).
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Walgreens Boots Alliance, Inc.
  4. Stock Walgreens Boots Alliance Inc - Nyse